InVivoSIM anti-human HER2 (Trastuzumab Biosimilar)
SIM0005
ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, Other Application
Product group Antibodies
Overview
- SupplierBio X Cell
- Product NameInVivoSIM anti-human HER2 (Trastuzumab Biosimilar)
- Delivery Days Customer7
- ApplicationsFunctional Assay, Flow Cytometry, Western Blot, ELISA, ImmunoHistoChemistry, Other Application
- CertificationResearch Use Only
- ClonalityMonoclonal
- Clone IDTrastuzumab
- Concentration4-11 mg/ml
- Estimated Purity>95%
- HostHuman
- IsotypeIgG1
- Storage Instruction2°C to 8°C
- UNSPSC12352203
References
- Jarvi NL, Balu-Iyer SV. A mechanistic marker-based screening tool to predict clinical immunogenicity of biologics. Commun Med (Lond). 2023,3(1):174. doi: 10.1038/s43856-023-00413-7Read this paper
- Lee D, Dunn ZS, Guo W, et al. Unlocking the potential of allogeneic Vδ2 T cells for ovarian cancer therapy through CD16 biomarker selection and CAR/IL-15 engineering. Nat Commun. 2023,14(1):6942. doi: 10.1038/s41467-023-42619-2Read this paper
- Hsu YP, Nourzaie O, Tocher AE, et al. Site-Specific Antibody Conjugation Using Modified Bisected N-Glycans: Method Development and Potential toward Tunable Effector Function. Bioconjug Chem. 2023,34(9):1633-1644. doi: 10.1021/acs.bioconjchem.3c00302Read this paper
- Sun W, Wang X, Wang D, et al. CD40×HER2 bispecific antibody overcomes the CCL2-induced trastuzumab resistance in HER2-positive gastric cancer. J Immunother Cancer. 2022,10(7). doi: 10.1136/jitc-2022-005063Read this paper
Datasheet
Related products
Product group Antibodies
ApplicationsFunctional Assay, ELISA, Neutralisation/Blocking
- SizePrice
Product group Antibodies
References
ApplicationsFlow Cytometry, ImmunoFluorescence, ImmunoPrecipitation, Other Application
- SizePrice